BioFlorida Masthead
JOIN BIOFLORIDA      MEMBERS ONLY      CALENDAR OF EVENTS      NEWS      CONTACT US

 

blue gradient

Founded in 1997 to advance Florida's bioscience industry, BioFlorida is a member-based organization working to support the growth of biotechnology, pharmaceuticals and medical technologies. To establish Florida as a worldwide leader in the biosciences, BioFlorida's leadership and programs positively influence the growth of the industry, including initiatives related to capital formation, public policy, workforce development, education and commercialization of research. BioFlorida represents approximately 200 member companies/organizations and continues to build partnerships and solid relationships focused on the industry's needs and the organization's mission.

BioFlorida 11th Annual Conference


Upcoming Events
BioPartnering Europe
  Sunday, October 12, 2008
London, England
More Information
BioFlorida's 11th Annual Conference
  Sunday, October 19, 2008
The Ritz-Carlton, Amelia Island (located outside of Jacksonville)
More Information
Party in the Park: BioFlorida NE Chapter Event
  Thursday, October 30, 2008
Progress Corporate Park, Alachua, FL
More Information

View all upcoming events.

News and Spotlight
 10/7/2008- Biovest Announces BiovaxID® Anti-Cancer Vaccine Prolongs Cancer-Free Survival by 44%: -Company Closes Phase 3 Fast-Tracked Clinical Trial -Will Petition to Offer All Study Patients Treatment with BiovaxID -Intends to Seek Approval in the U.S. and Internationally ...
 
 9/30/2008- Torrey Pines Institute for Molecular Studies’ 103,000-Square-Foot Facility : Months ahead of schedule, the anchor tenant of the Florida Center for Innovation at Tradition (FCI) accepted its Certificate of Occupancy from Port St. Lucie officials today, making the Torrey Pines Institute for Molecular Studies (TPIMS) the first a ...
 
 9/30/2008- Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure : Bioheart, Inc., (Nasdaq:BHRT), today announced that 35 of the leading U.S. Heart Failure Centers have engaged in Bioheart’s Phase II/III MARVEL1 Trial of myogenic cells for treating advanced heart failure. ...
 

View all news.

blue gradient leadership members























| About BioFlorida | Membership | Resource Center | Contact Us | 11th Annual Conference  
 © 2008 BIOFLORIDA. All rights reserved.